A Trial to Reduce Pneumonia in Nursing Home Residents
Phase 3
Completed
- Conditions
- PneumoniaLower Respiratory Tract Infection
- Interventions
- Other: Enhanced Oral CareOther: Usual oral care
- Registration Number
- NCT00975780
- Lead Sponsor
- Yale University
- Brief Summary
The purpose of this study is to test the effectiveness of an enhanced oral hygiene protocol in preventing pneumonia among nursing home residents.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 834
Inclusion Criteria
- long term care resident of nursing home
- residents age >65
- residents of nursing home for at least one month
- residents having at least one of two modifiable risk factors for pneumonia (i.e., impaired oral hygiene, swallowing difficulty)
Read More
Exclusion Criteria
- residents housed in nursing home for short term rehabilitation
- residents who receive nourishment by tube feeding
- residents who have a life expectancy < 3 months
- residents who have been diagnosed with pneumonia within the previous 6 weeks
- residents who are currently using oral chlorhexidine
- residents who have previously been enrolled in the study
- residents, or their designated proxies, who are unwilling to give informed consent
- residents who have tracheostomy
- residents who are non-english speaking
- residents who the administrator leadership of the home felt were not appropriate for the study
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description enhanced oral care Enhanced Oral Care - Usual care Usual oral care The usual oral care provided at the nursing home
- Primary Outcome Measures
Name Time Method Pneumonia 2.5 years The number of participants that recorded a 'first pneumonia' during the 2.5 years timeframe.
- Secondary Outcome Measures
Name Time Method Lower Respiratory Tract Infection Other Than Pneumonia 2.5 years The number of participants that recorded a 'lower respiratory tract infection other than pneumonia' during the 2.5 years timeframe.
Trial Locations
- Locations (1)
Yale University School of Medicine
🇺🇸New Haven, Connecticut, United States